Skip to main navigation Skip to search Skip to main content

In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody

  • James G. Krueger
  • , Brian S. Kim
  • , Stephan Weidinger
  • , Yoko Kataoka
  • , John T. O’malley
  • , Karl Yen
  • , Cassie VAN KRINKS
  • , Jose Vela

Research output: Contribution to journalComment/debate

3 Scopus citations
Original languageEnglish
Article numberadv43608
JournalActa Dermato-Venereologica
Volume105
DOIs
StatePublished - 2025

Keywords

  • ADCC
  • OX40L
  • T cells
  • amlitelimab
  • atopic dermatitis
  • inflammation
  • non depletion
  • regulatory T-cells

Cite this